Comparison of the demographics of patients enrolled in the melatonin and placebo treatment arm.
| Category . | Melatonin N = 40 . | Placebo N = 38 . | P-value . |
|---|---|---|---|
| Age (year, median [range]) | 59.5 (35-73) | 60.0 (38-78) | .391 |
| Race (n [%]) | |||
| Black or African American | 10 (25.0) | 11 (29.0) | .7338 |
| White | 27 (67.5) | 26 (68.4) | |
| Other | 3 (7.5) | 1 (2.6) | |
| Category . | Melatonin N = 40 . | Placebo N = 38 . | P-value . |
|---|---|---|---|
| Age (year, median [range]) | 59.5 (35-73) | 60.0 (38-78) | .391 |
| Race (n [%]) | |||
| Black or African American | 10 (25.0) | 11 (29.0) | .7338 |
| White | 27 (67.5) | 26 (68.4) | |
| Other | 3 (7.5) | 1 (2.6) | |
The median age, race, and performance status of study patients were similar and demonstrated no statistically significant difference between the 2 groups.
Comparison of the demographics of patients enrolled in the melatonin and placebo treatment arm.
| Category . | Melatonin N = 40 . | Placebo N = 38 . | P-value . |
|---|---|---|---|
| Age (year, median [range]) | 59.5 (35-73) | 60.0 (38-78) | .391 |
| Race (n [%]) | |||
| Black or African American | 10 (25.0) | 11 (29.0) | .7338 |
| White | 27 (67.5) | 26 (68.4) | |
| Other | 3 (7.5) | 1 (2.6) | |
| Category . | Melatonin N = 40 . | Placebo N = 38 . | P-value . |
|---|---|---|---|
| Age (year, median [range]) | 59.5 (35-73) | 60.0 (38-78) | .391 |
| Race (n [%]) | |||
| Black or African American | 10 (25.0) | 11 (29.0) | .7338 |
| White | 27 (67.5) | 26 (68.4) | |
| Other | 3 (7.5) | 1 (2.6) | |
The median age, race, and performance status of study patients were similar and demonstrated no statistically significant difference between the 2 groups.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
